Iron metabolism and cardiovascular disease: Basic to translational purviews and therapeutical approach

Mihai Lupu1, Diana Tudor1, Adriana Filip1

  • 1Iuliu Hatieganu University of Medicine and Pharmacy, Department of Physiology, Cluj-Napoca, Romania.

Insights

This review explores iron

Area of Science:

  • Cardiovascular Science
  • Nutritional Biochemistry
  • Pathophysiology

Background:

  • Iron's role in cardiovascular health is complex and not fully understood.
  • While beneficial in chronic heart failure, its impact on acute events like myocardial infarction and stroke is understudied.
  • Iron's redox properties may influence atherosclerosis, necrosis, and ferroptosis.

Purpose of the Study:

  • To review the literature on iron's temporal effects in cardiovascular diseases.
  • To elucidate the pathophysiological mechanisms of iron's involvement.
  • To highlight current and potential treatment strategies.

Main Methods:

  • Comprehensive literature review of studies on iron and cardiovascular diseases.
  • Analysis of pathophysiological mechanisms involving iron's redox activity.
  • Synthesis of findings related to acute and chronic cardiovascular conditions.

Main Results:

  • Evidence suggests iron benefits chronic heart failure patients with deficiency.
  • Acute cardiovascular events like myocardial infarction and stroke have limited randomized controlled trial data.
  • Iron's dual redox nature is implicated in atherosclerosis, necrosis, and ferroptosis.

Conclusions:

  • Further research is needed on iron's role in acute cardiovascular diseases.
  • Understanding iron's complex mechanisms can inform targeted therapeutic interventions.
  • Intravenous iron may be beneficial in specific cardiovascular contexts, warranting further investigation.

Related Concept Videos

Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
14.9K
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
27
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
46
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
284
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
20
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
65